Poland, on Friday recognized India’s Covishield as a COVID-19 vaccine equivalent to those recognized by the European Union, exempting Covishield-vaccinated individuals from quarantine after entering the territory of the Republic of Poland – the Embassy of Poland in New Delhi said on Friday.
“Poland has recognized #Covishield as a vaccine equivalent to those recognized by the European Union, exempting from quarantine after entering the territory of the Republic of Poland,” the Polish Embassy in New Delhi said in a tweet.
In July, Belgium recognised Covishield vaccine, which has been developed by Oxford-AstraZeneca and is being produced by the Serum Institute of India (SII).
“Belgium recognises Covishield, the Astra Zeneca vaccine produced by Serum Institute of India and distributed by COVAX. An important decision for India, Nepal, Bhutan, Sri Lanka, Maldives, Bangladesh in the fight against vaccine inequality,” the embassy of Belgium in India said.
Charge d’affaires of Belgium embassy, Arnaud Lion said that recognition of Covishield by his country will have a positive impact for everyone getting the vaccine shot in India and abroad.
In fact, India had also warned and subsequently, taken reciprocating action against UK nationals making it mandatory for them to undergo quarantine upon arrival in India. The decision was reversed after the UK recognised the vaccine and waived off the mandatory quarantine for Indians arriving in that country. London also clarified that it had issues, not with the vaccine, but with India’s vaccine certification process.
India has urged several European countries to grant recognition to Covishield and other Indian vaccines for Indian nationals travelling to Europe. Covishield, the Oxford-AstraZeneca vaccine, is manufactured by the Serum Institute of India. Besides UK and Poland, Australia has also recognised Covishield.
